Cadence Expands Pfizer’s License to Molecular Design Software

SAN JOSE, Calif.–(BUSINESS WIRE)–Cadence Molecular Sciences (OpenEye) announced today that Pfizer Inc. has signed an agreement to extend and expand access to Cadence products.
Click here to view original post